Elanco

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Elanco and other ETFs, options, and stocks.

About ELAN

Elanco Animal Health, Inc. develops, manufactures, and markets products for pets and farm animals. Its products include Advantage Family, Atopica, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, TruCan, AviPro, Baytril, Catosal, Denagard, and Experior. 

CEO
Jeffrey N. Simmons
CEOJeffrey N. Simmons
Employees
9,450
Employees9,450
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1954
Founded1954
Employees
9,450
Employees9,450

ELAN Key Statistics

Market cap
12.23B
Market cap12.23B
Price-Earnings ratio
338.55
Price-Earnings ratio338.55
Dividend yield
Dividend yield
Average volume
5.66M
Average volume5.66M
High today
$25.02
High today$25.02
Low today
$24.50
Low today$24.50
Open price
$24.74
Open price$24.74
Volume
2.63M
Volume2.63M
52 Week high
$25.29
52 Week high$25.29
52 Week low
$8.02
52 Week low$8.02

Stock Snapshot

As of today, Elanco(ELAN) shares are valued at $24.62. The company's market cap stands at 12.23B, with a P/E ratio of 338.55.

As of 2026-01-27, Elanco(ELAN) stock has fluctuated between $24.50 and $25.02. The current price stands at $24.62, placing the stock +0.5% above today's low and -1.6% off the high.

The Elanco(ELAN)'s current trading volume is 2.63M, compared to an average daily volume of 5.66M.

In the last year, Elanco(ELAN) shares hit a 52-week high of $25.29 and a 52-week low of $8.02.

In the last year, Elanco(ELAN) shares hit a 52-week high of $25.29 and a 52-week low of $8.02.

ELAN News

Simply Wall St 19h
Elanco Approvals And Clinic Gains Shape Updated Valuation Outlook

Elanco Animal Health (NYSE:ELAN) has secured USDA approval for Befrena, a new product in its portfolio. The company has also received conditional FDA approval...

Elanco Approvals And Clinic Gains Shape Updated Valuation Outlook
TipRanks 6d
Piper upgrades Elanco to Overweight on new growth driver

Piper Sandler analyst David Westenberg upgraded Elanco (ELAN) to Overweight from Neutral with a price target of $30, up from $24. After attending the VMX confer...

Analyst ratings

78%

of 18 ratings
Buy
77.8%
Hold
16.7%
Sell
5.6%

People also own

Based on the portfolios of people who own ELAN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.